01875.HK
BioDlink International Company Limited
HKSE · Healthcare · Biotechnology · CN
HKD 3.82
−0.39%Margins
Gross margin
17.5%
EBITDA margin
-8.1%
EBIT margin
-30.7%
Net margin
-32.4%
FCF margin
-8.1%
-26.4%
Return on equity
-13.8%
Return on assets
-15.9%
Return on invested capital
0.41x
Asset turnover
-HKD 21.8M
Cash from operations
HKD 0.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026